Σύμφωνα με τα κριτήρια της UEMS - EACCME χορηγούνται 20 μόρια Συνεχιζόμενης Ιατρικής Εκπαίδευσης (CME-CPD credits).
Χορηγοί
VIATRIS
AMGEN
BOEHRINGER INGELHEIM
NOVARTIS
ASTRAZENECA
LILLY
WINMEDICA
ALEXION
AMRYT
BAYER
CHIESI
COLLABORATE
ELPEN
INNOVIS
LAVIPHARM
LIBYTEC
MENARINI HELLAS
NOVO NORDISK
OMEGA PHARMA
PFIZER
RAFARM
SANOFI
SERVIER
UNI PHARMA
VELKA
BIANEX
EAS-HAS
Joint event
Saturday,
December 4th, 2021
12.00 - 14.00
The 9th Panhellenic Congress of the Working Groups of the Hellenic Atherosclerosis Society, will be held in Eastern European Summer Time Zone (EEST) (CET+1 or GMT+3)
On line Registration for EAS Members
Free registration is valid only for Members of the European Atherosclerosis Society.
Link & username will be sent to you a few days before the Congress.
Chairpersons
K. Ray
E. Liberopoulos
Welcome address from the EAS National Society Coordinator
A. Zambon 
Associate Professor of Medicine, Department of Medicine, University of Padua School of Medicine, Italy; Affiliate Assistant Professor of Medicine, Division of Endocrinology, Metabolism and Nutrition, School of Medicine, University of Washington, Seattle, WA, USA
Alterations in lipid metabolism on COVID-19: Prognostic considerations and therapeutic options
A. Reda
Professor of cardiology, Menoufia University, Shebin Elkom, Menofia, Egypt
President of EAVA society
Moving healthcare systems towards preserving health rather than treating disease
K. Ray
Professor of Public Heath Department of Public Health and Primary Care Honorary Consultant Cardiologist Director, Imperial Centre for CVD Prevention Deputy Director, Imperial Clinical Trials Unit Head, Commercial Trials Imperial College London, London, UK, President of European Atherosclerosis Society
Current status of patients with dyslipidemia in Greece
E. Liberopoulos
Professor of Medicine-Metabolic Diseases, School of Medicine, National and Kapodistrιan University of Athens, 1st Propedeutic Department of Medicine and Diabetes Center, Laiko General Hospital
Predictive value of body fat distribution on the severity of coronary atherosclerosis: Insights from a Tunisian study
H. Gamra
Professor of Medicine, Monastir University, Head, Cardiology Department A, Fattouma Bourguiba University Hospital, Tunisia
Rapid and effective achievement of LDL-C goals in very high CV risk patients: Available strategies and clinical implications
A. Zambon
Associate Professor of Medicine, Department of Medicine, University of Padua School of Medicine, Italy; Affiliate Assistant Professor of Medicine, Division of Endocrinology, Metabolism and Nutrition, School of Medicine, University of Washington, Seattle, WA, USA
The role of Inflammation, Lp(a) and remnants in the residual Cardiovascular. Risk at Low LDL-cholesterol levels
A. Tselepis
Professor of Biochemistry-Clinical Chemistry, Atherothrombosis Research Centre / Department of Chemistry, University of Ioannina
ΠΕΜΠΤΗ 2 ΔΕΚΕΜΒΡΙΟΥ 2021 | 14.00-15.45
ΑΝΟΙΧΤΗ ΕΚΔΗΛΩΣΗ ΚΟΙΝΟΥ
Τρόπος ζωής και Καρδιαγγειακή νόσος: Από τους Παθοφυσιολογικούς μηχανισμούς στην Κλινική πράξη (CARDIOLIFE).
ΔΩΡΕΑΝ ΣΥΜΜΕΤΟΧΗ
Keep updated about all events
Επικοινωνία:
|
Επιστημονικός Φορέας Οργάνωσης:
Ελληνική Εταιρεία Αθηροσκλήρωσης |
Organizing -Administrative Bureau/ Secretariat:
Conferre SA: "The Art of Bringing People Together".
- Stavrou Niarchou Ave., Mares Position
GR455 00 Pedini, Ioannina, GREECE - +30 26510 68610
- +30 26510 68611
- info@conferre.gr
